Research & Development

国产情侣av偷拍视频天天啪之夜夜欢天天很天天情天天透狠se手机网彭博:华为计划在北欧开设旗舰店 或选斯德哥尔摩

發布時間︰

  “褚楚啊,雲氏沒有奴僕了。”   還不錯,這孩子的燒退了一些,不過,還是要主意,到了晚上可能會有反復。国产情侣av偷拍视频天天啪之夜夜欢   孤王如果登基,昌邑王難逃一死,昌邑王如果……如果……登基,孤王也只有死路一條。天天很天天情天天透   雲瑯皺眉道︰“是的。”   “去病呢?”狠se手机网   “看看有沒有得罪天顏之處。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo